May & Baker Nigeria Plc, together with its subsidiaries, manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. It operates through Pharmaceuticals and Beverage segments. The company offers pharmaceuticals, including anti-diabetic, anti-hypersensitive, anti-infective, anti-malaria, analgesic, cough and cold, and anxiolytics; and nature care products. It also provides beverage drinks, including bottled water under the Lily Water name; and hand and surface sanitizers under the Smartans name. In addition, the company engages in contract manufacturing of pharmaceutical products; and in healthcare and industrial packaging. May & Baker Nigeria Plc was incorporated in 1944 and is headquartered in Lagos, Nigeria.
Metrics to compare | MAYBAKE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMAYBAKEPeersSector | |
---|---|---|---|---|
P/E Ratio | 6.5x | 0.0x | −0.6x | |
PEG Ratio | 0.61 | 0.00 | 0.00 | |
Price/Book | 1.2x | 0.0x | 2.6x | |
Price / LTM Sales | 0.5x | 0.0x | 3.1x | |
Upside (Analyst Target) | 11.0% | 0.0% | 58.1% | |
Fair Value Upside | Unlock | 0.0% | 9.2% | Unlock |